Cargando…

Readability of COVID-19 vaccine information for the general public

BACKGROUND: More than 130 million individuals in the United States have now received at least one dose of a COVID-19 vaccine. Currently, all adults in the Unites States now have access to one of three COVID-19 vaccines. As part of the vaccination procedure, Emergency Use Authorization (EUA) fact she...

Descripción completa

Detalles Bibliográficos
Autores principales: Bothun, Luke S., Feeder, Scott E., Poland, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061131/
https://www.ncbi.nlm.nih.gov/pubmed/35534313
http://dx.doi.org/10.1016/j.vaccine.2022.04.096
_version_ 1784698662088081408
author Bothun, Luke S.
Feeder, Scott E.
Poland, Gregory A.
author_facet Bothun, Luke S.
Feeder, Scott E.
Poland, Gregory A.
author_sort Bothun, Luke S.
collection PubMed
description BACKGROUND: More than 130 million individuals in the United States have now received at least one dose of a COVID-19 vaccine. Currently, all adults in the Unites States now have access to one of three COVID-19 vaccines. As part of the vaccination procedure, Emergency Use Authorization (EUA) fact sheets, which contain information regarding the vaccine, are provided. The purpose of this study was to analyze the ease of reading (i.e., readability) of the EUA-approved fact sheets for the vaccines currently available in the United States, the V-Safe adverse event survey script, and the Centers for Disease Control and Prevention (CDC) website information on COVID-19 vaccines designed for the general public in the United States. METHODS: We acquired the Pfizer, Moderna, and Janssen EUA fact sheets, as well as the V-Safe survey script and the CDC website information regarding COVID-19 vaccines. These documents were analyzed for their complexity regarding the following readability factors: average length of paragraphs, sentences, and words; font size and style; use of passive voice; the Gunning-Fog index; the Flesch Reading Ease index; and the Flesch-Kincaid Grade Level index. RESULTS: Only the V-Safe adverse-event survey script met readability standards for adequate comprehension. The mean readability scores of the EUA fact sheets and the CDC website were as follows: Flesch Reading Ease score (44.35 avg); Flesch-Kincaid Grade Level (10.48 avg); and Gunning-Fog index (11.8 avg). These scores indicate that at least a 10th-grade level education would be required to understand these reading materials. CONCLUSION: The average person in the United States would have difficulty understanding the information provided in the EUA fact sheets and CDC COVID-19 vaccine website documents; however, the V-Safe survey was written at an adequate reading level. To ensure that the general public fully understands information regarding COVID-19 vaccines, greater care and effort should be given to the development of simplified information material.
format Online
Article
Text
id pubmed-9061131
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90611312022-05-03 Readability of COVID-19 vaccine information for the general public Bothun, Luke S. Feeder, Scott E. Poland, Gregory A. Vaccine Article BACKGROUND: More than 130 million individuals in the United States have now received at least one dose of a COVID-19 vaccine. Currently, all adults in the Unites States now have access to one of three COVID-19 vaccines. As part of the vaccination procedure, Emergency Use Authorization (EUA) fact sheets, which contain information regarding the vaccine, are provided. The purpose of this study was to analyze the ease of reading (i.e., readability) of the EUA-approved fact sheets for the vaccines currently available in the United States, the V-Safe adverse event survey script, and the Centers for Disease Control and Prevention (CDC) website information on COVID-19 vaccines designed for the general public in the United States. METHODS: We acquired the Pfizer, Moderna, and Janssen EUA fact sheets, as well as the V-Safe survey script and the CDC website information regarding COVID-19 vaccines. These documents were analyzed for their complexity regarding the following readability factors: average length of paragraphs, sentences, and words; font size and style; use of passive voice; the Gunning-Fog index; the Flesch Reading Ease index; and the Flesch-Kincaid Grade Level index. RESULTS: Only the V-Safe adverse-event survey script met readability standards for adequate comprehension. The mean readability scores of the EUA fact sheets and the CDC website were as follows: Flesch Reading Ease score (44.35 avg); Flesch-Kincaid Grade Level (10.48 avg); and Gunning-Fog index (11.8 avg). These scores indicate that at least a 10th-grade level education would be required to understand these reading materials. CONCLUSION: The average person in the United States would have difficulty understanding the information provided in the EUA fact sheets and CDC COVID-19 vaccine website documents; however, the V-Safe survey was written at an adequate reading level. To ensure that the general public fully understands information regarding COVID-19 vaccines, greater care and effort should be given to the development of simplified information material. Elsevier Ltd. 2022-05-31 2022-05-03 /pmc/articles/PMC9061131/ /pubmed/35534313 http://dx.doi.org/10.1016/j.vaccine.2022.04.096 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bothun, Luke S.
Feeder, Scott E.
Poland, Gregory A.
Readability of COVID-19 vaccine information for the general public
title Readability of COVID-19 vaccine information for the general public
title_full Readability of COVID-19 vaccine information for the general public
title_fullStr Readability of COVID-19 vaccine information for the general public
title_full_unstemmed Readability of COVID-19 vaccine information for the general public
title_short Readability of COVID-19 vaccine information for the general public
title_sort readability of covid-19 vaccine information for the general public
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061131/
https://www.ncbi.nlm.nih.gov/pubmed/35534313
http://dx.doi.org/10.1016/j.vaccine.2022.04.096
work_keys_str_mv AT bothunlukes readabilityofcovid19vaccineinformationforthegeneralpublic
AT feederscotte readabilityofcovid19vaccineinformationforthegeneralpublic
AT polandgregorya readabilityofcovid19vaccineinformationforthegeneralpublic